Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis

Documenti analoghi

• Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
  di: Francesca Perutelli, et al.
  Pubblicazione: (2025)
• Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
  di: Xiaolu Zhu, et al.
  Pubblicazione: (2025)
• Isolated testicular second‐relapsed T‐lymphoblastic lymphoma after allogeneic stem cell transplantation: Therapeutic implication from sequential molecular genetic analysis
  di: Kohei Fukuoka, et al.
  Pubblicazione: (2024)
• Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
  di: Francesca A. M. Kinsella, et al.
  Pubblicazione: (2024)
• Monitoring the KMT2A gene post‐chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation
  di: Jing Liu, et al.
  Pubblicazione: (2025)